Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

被引：0
|
作者：
A. N. Aravindan
Venkatesh Moger
Vinay Sakhuja
Harbir S. Kohli
Neelam Varma
Vivekanand Jha
机构：
[1] Postgraduate Institute of Medical Education and Research,Departments of Nephrology
[2] Hematology,undefined
[3] Postgraduate Institute of Medical Education and Research,undefined
来源：
International Urology and Nephrology | 2006年 / 38卷
关键词：
Kidney transplantation; Posttransplant lymphoproliferative disorder; Hepatitis C; Immunosuppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD 11 months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.
引用
收藏
页码：355 / 357
页数：2
相关论文
共 50 条
  • [41] Rothia dentocariosa sepsis in a pediatric renal transplant recipient having post-transplant lymphoproliferative disorders
    Wiesmayr, S
    Stelzmueller, I
    Berger, N
    Jungraithmayr, TC
    Fille, M
    Eller, M
    Zimmerhackl, LB
    Margreiter, R
    Bonatti, H
    PEDIATRIC TRANSPLANTATION, 2006, 10 (03) : 377 - 379
  • [42] Post-transplant lymphoproliferative disorder presenting as a tumor adjacent to the renal allograft: A case report and review of the literature
    Gao, Chen
    Peng, Longkai
    Peng, Fenghua
    Tuo, Ting
    Li, Daiqiang
    ONCOLOGY LETTERS, 2014, 8 (06) : 2607 - 2610
  • [43] Three different histological subtypes of Epstein–Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection
    Mikiko Kobayashi
    Naoko Asano
    Mana Fukushima
    Takayuki Honda
    International Journal of Hematology, 2014, 100 : 307 - 311
  • [44] Calcineurin inhibition and disease recurrence in the hepatitis C virus-positive liver transplant recipient
    Pollard, S
    LIVER INTERNATIONAL, 2004, 24 (05) : 402 - 406
  • [45] Management of hepatitis C infection in renal transplant recipients
    Natov, SN
    Pereira, BJG
    AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (06) : 483 - 490
  • [46] Adenotonsillar hypertrophy and post-transplant lymphoproliferative disorder in pediatric renal transplant recipients
    Sabine Köpf
    Burkhard Tönshoff
    Pediatric Nephrology, 2004, 19 : 471 - 472
  • [47] Post-transplant lymphoproliferative disorder presenting with skin ulceration in a renal transplant recipient who achieved sustained remission with rituximab therapy: A case report
    Law, Man Fai
    Chan, Hay Nun
    Lai, Ho Kei
    Ha, Chung Yin
    Ng, Celia
    Yeung, Yiu Ming
    Yip, Sze Fai
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (05) : 610 - 612
  • [48] Adverse Impact of Hepatitis C Virus Infection on Renal Replacement Therapy and Renal Transplant Patients in Australia and New Zealand
    Scott, David R.
    Wong, Jeffrey K. W.
    Spicer, Tim S.
    Dent, Hanna
    Mensah, Fiona K.
    McDonald, Stephen
    Levy, Miriam T.
    TRANSPLANTATION, 2010, 90 (11) : 1165 - 1171
  • [49] REVIEW: Hepatitis C Virus Infection and Lymphoproliferative Disorders
    Luis R. Peña
    Sucha Nand
    Nicola De Maria
    David H. Van Thiel
    Digestive Diseases and Sciences, 2000, 45 : 1854 - 1860
  • [50] Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients
    Aljumah, Abdulrahman A.
    Saeed, Mohamed A.
    Al Flaiw, Ahmed I.
    Al Traif, Ibrahim H.
    Al Alwan, Abduljaleel M.
    Al Qurashi, Salem H.
    Al Ghamdi, Ghormallah A.
    Al Hejaili, Fayez F.
    Al Balwi, Mohammed A.
    Al Sayyari, Abdulla A.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (01) : 55 - 63
12345